JERSEY CITY, N.J., June 21, 2024 /PRNewswire/ -- InsightAce Analytic
Pvt. Ltd. announces the release of a market assessment report on
the "Global Molecular Pharming Market Size, Share &
Trends Analysis Report By Crop Source (Maize, Barley, Tobacco,
Safflower, Rice, Alfalfa), By Technology (Gene Gun, Agroinfiltration, Electroporation,
Agrobacterium-Mediated Gene Transfer), By Application (Recombinant
Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins &
Protein-Based Materials, Technical Reagents, Nutritional Products),
By End User (Biotechnology & Pharmaceutical Companies, Contract
Manufacturing Organizations)- Market Outlook And Industry Analysis
2031"
The Global Molecular Pharming Market is valued at
US$ 457.7 Mn in 2023, and it is
expected to reach US$ 1,399.8 Mn by
2031, with a CAGR of 15.3% during the forecast period of
2024-2031.
Download Free Sample and ToC of the Report:
https://www.insightaceanalytic.com/request-sample/1712
Molecular pharming refers to biologics production in plant
systems to reduce the cost of microbial systems. Molecular farming
is an innovative method for producing molecular medicines,
including plasma proteins, enzymes, growth factors, vaccinations,
and recombinant antibodies. These medicines have widely accepted
medicinal uses at a molecular level. The approach has the potential
to change the pharmaceutical industry by providing highly efficient
and cost-effective treatments to all segments of the population.
Plant-based protein expression offers practical, secure, efficient,
and cost-effective advantages.
Molecular pharming has the potential to offer a new platform for
the development and delivery of vaccines and therapeutics for
infectious diseases, particularly in low-resource environments. It
can also contribute to improving human health and well-being by
generating proteins that can regulate various physiological
functions, including growth, metabolism, reproduction, and
immunity.
By encouraging innovation, collaboration, and diversification,
molecular pharming can also generate novel opportunities for the
biotechnology sector and the entrepreneurial landscape. It can
potentially facilitate the creation of innovative products and
services that can directly address unmet medical requirements and
market demands. The global molecular pharmaceutical industry will
rise rapidly due to the expansion of studies into producing
pharmaceuticals from plants and products. The sudden demand for
precision medicine and its production from natural and organic
sources will contribute to the market's growth during the next five
years.
List of Prominent Players in the Molecular Pharming
Market:
- Leaf Expression Systems
- ORF Genetics hf.
- Agrenvec S.L.
- PlantForm
- Protalix Biotherapeutics
- Kbio, Inc.
- Cape Biologix Technologies (Cape Bio Pharms)
- Bright Biotech
- Moolec Science SA
- Miruku
- Tiamat Sciences Corp.
- IngredientWerks
- Core Biogenesis
- Diamante Società Benefit S.r.l.
- Elo Life Systems
- G+FLAS Life Sciences, Inc.
- BIOBETTER
- MOZZA FOODS
- FORTE PROTEIN INC.
- KYOMEI
- NOBELL FOODS
- PIGMENTUM
- MNPHARM
- Finally Foods
- Tiamat Sciences
- POLOPO Ltd.
- VELOZBIO
- newmoo Foods
- BionFarming GmbH
Molecular Pharming Market Report Scope:
Report
Attribute
|
Specifications
|
Market Size Value In
2023
|
USD 457.7 Mn
|
Market Size Value In
2031
|
USD 1.399.8
Mn
|
Growth rate
CAGR
|
CAGR of 15.3% from 2023
to 2031
|
Quantitative
units
|
Representation of
revenue in US$ Mn, and CAGR from 2024 to 2031
|
Historic
Year
|
2019 to 2023
|
Forecast
Year
|
2024-2031
|
Report
coverage
|
The forecast of
revenue, the position of the company, the competitive market
statistics, growth prospects, and trends
|
Segments
covered
|
By Crop Type,
Technology, Applications and End Users
|
Regional
scope
|
North America; Europe;
Asia Pacific; Latin America; Middle East & Africa
|
Country
scope
|
U.S.; Canada; U.K.;
Germany; China; India; Japan; Brazil; Mexico; The UK; France;
Italy; Spain; China; Japan; India; South Korea; Southeast Asia;
South Korea; Southeast Asia
|
Order 180 Pages Full Report @
https://www.insightaceanalytic.com/buy-report/1712
Market Dynamics:
Drivers-
The rising need for biologics to target complicated illnesses
and decrease side effects compared to traditional small-molecule
medications will drive market expansion, and molecular pharming
offers a viable option to address this demand by providing a
cost-effective and scalable technology for biologic production.
Furthermore, increased investment in R&D activities related
to molecular pharming, growing awareness of its benefits, and
advancements in gene editing technologies that allow for precise
modification of host organisms for higher yields and improved
product quality drive its adoption, resulting in market growth.
Moreover, Numerous partnerships have been formed between industry
and non-industry groups to develop plant-based treatments. The
global market for molecular pharming is anticipated to expand at a
healthy rate due to factors such as the rising prevalence of
disease indications, rising demand for biologics, ongoing efforts
to advance the development of such products, and further
optimization of the related technologies.
Challenges:
Several issues, including depletion of natural resources and
environmental degradation, restrict crop production. Furthermore, a
lack of public awareness restricts the market's growth.
Regional Trends:
The North American molecular pharming market is expected to
register a considerable market share in revenue. It is projected to
grow at a high CAGR shortly area is a pioneer in implementing new
technologies. The region's market has a high revenue due to factors
including expanding government efforts that boost the
implementation of modern agriculture technologies and established
infrastructure. Besides, Asia
Pacific has a substantial share in the molecular pharming
market in emerging nations like India, China,
and Australia. Numerous government
projects are being carried out to promote contemporary precision
agricultural technologies, increasing production.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1712
Recent Developments:
- In October 2023, Moolec
Science, involved in development of animal proteins using plants
through molecular pharming, raised $30M in cash and kind from investors via
convertible notes. The company intends to focus on additional meat
molecules and proteins in a variety of R&D initiatives. Instead
of isolating and purifying the animal protein from sources, the
company intends to offer soy and pea proteins with the meat
proteins integrated in the matrix.
- In Sep 2023, BioBetter, a
FoodTech startup, launched its first food-grade pilot facility in
northern Israel to expedite
production of growth factors for cultivated meat. Using tobacco
plants as self-sustained bioreactors, they aim to produce 100kg
daily, scaling up to 5 tons by 2025, lowering costs for the
industry.
- In Nov 2022, Bright
Biotech completed a financing round of $3.2
million. With this funding, the company is planning to
invest in research and development for a novel genetic engineering
technology to produce growth factors, increase its staff of
prominent scientists, and scale up its manufacturing processes. The
technique of the company extracts valuable proteins from the
chloroplasts of plants, which can allow grown meat companies to
reach affordable industrial manufacturing.
Segmentation of Molecular Pharming Market-
By Crop Source:
- Maize
- Barley
- Tobacco
- Safflower
- Rice
- Alfalfa
By Technology:
- Gene Gun
- Agroinfiltration
- Electroporation
- Agrobacterium-Mediated Gene Transfer
- Others
By Application:
- Recombinant Antibodies
- Hormones
- Vaccines
- Industrial Enzymes
- Proteins & Protein-Based Materials
- Technical Reagents
- Nutritional Products
- Others
By End User:
- Biotechnology & Pharmaceutical Companies
- Contract Manufacturing Organizations
- Others
By Region-
North America-
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and
Africa
For More Customization @
https://www.insightaceanalytic.com/customisation/1712
Why should buy this report:
- To receive a comprehensive analysis of the prospects for global
Molecular Pharming market
- To receive industry overview and future trends of global
Molecular Pharming market
- To analyze the Molecular Pharming market drivers and
challenges
- To get information on the Molecular Pharming market size value
(US$ Mn) forecast till 2031
- Major Investments, Mergers & Acquisition in global
Molecular Pharming industry
Other Related Reports Published by InsightAce
Analytic:
Plant-Based Vaccines Market
Plant-based Expression Systems Market
Plant Genetic Engineering Market
Plant Based API Market
Check Our Satisfied Clients Portfolio @
https://www.insightaceanalytic.com/our-clients
About Us:
InsightAce Analytic is a market research and consulting firm
that enables clients to make strategic decisions. Our qualitative
and quantitative market intelligence solutions inform the need for
market and competitive intelligence to expand businesses. We help
clients gain competitive advantage by identifying untapped markets,
exploring new and competing technologies, segmenting potential
markets and repositioning products. Our expertise is in providing
syndicated and custom market intelligence reports with an in-depth
analysis with key market insights in a timely and cost-effective
manner.
Contact Us:
InsightAce Analytic PVT. LTD
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Follow us on LinkedIn:
https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Logo:
https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/molecular-pharming-market-in-the-north-america-is-expected-to-register-the-highest-share-in-revenue-shortly---says-insightace-analytic-302178880.html